Psychoneuroimmunology of depression and its relation to the gut-brain axis
Literature review
Keywords:
depression, gut-brain Axis, microbiota, psychoneuroimmunology, psychosocialAbstract
Background: Psychoneuroimmunology (PNI) or also called psychoneuroendocrinology is the study of how psychological, neural, and immunological processes interact and influence human health and behavior. It is known that psychosocial factors contribute to the development of many diseases and that the immune system plays an important role in this relationship. Likewise, immune system signals in the brain affect mood, cognitive function, and behavior. Method: Literature review through scientific sources from books and journals related to the psychoneuroimmunology of depression and its relationship with the gut-brain axis. Discussion: Several studies have shown that patients with severe mental disorders including depression are affected by various changes in the gut microbiota and increased intestinal permeability. The gut microbiota can activate the Hypothalamic-Pituitary-Adrenal (HPA) axis through some mediators that cross the blood-brain barrier and include antigens, microbes, cytokines, and prostaglandins. Some bacterias release neurotransmitters that can interact directly with the vagus nerve. Hypothalamic-Pituitary-Adrenal axis activation can influence gut microbiota and gut permeability. An imbalance in intestinal flora can reduce protective properties, and increase neurotoxins and inflammatory mediators, causing nerve damage from the synaptic cleft which causes depression. Conclusion: There is an interrelated relationship between the psychoneuroimmunology of depression and the gut-brain axis.
Downloads
References
Alessi, M. G., & Bennett, J. M. (2020). Mental health is the health of the whole body: How psychoneuroimmunology & health psychology can inform & improve treatment. Journal of Evaluation in Clinical Practice, 26(5), 1539-1547.
Delaney, S., Fallon, B., Alaedini, A., Yolken, R., Indart, A., Feng, T., ... & Javitt, D. (2019). Inflammatory biomarkers in psychosis and clinical high risk populations. Schizophrenia research, 206, 440-443. https://doi.org/10.1016/j.schres.2018.10.017
Feng, T., McEvoy, J. P., & Miller, B. J. (2020). Longitudinal study of inflammatory markers and psychopathology in schizophrenia. Schizophrenia Research, 224, 58-66. https://doi.org/10.1016/j.schres.2020.10.003
Fond, G. B., Lagier, J. C., Honore, S., Lancon, C., Korchia, T., Verville, P. L. S. D., ... & Boyer, L. (2020). Microbiota-orientated treatments for major depression and schizophrenia. Nutrients, 12(4), 1024.
Fond, G., Lançon, C., Korchia, T., Auquier, P., & Boyer, L. (2020). The role of inflammation in the treatment of schizophrenia. Frontiers in psychiatry, 160.
Halaris, A. E., Belendiuk, K. T., & Freedman, D. X. (1975). Antidepressant drugs affect dopamine uptake. Biochemical Pharmacology.
Halaris, A., Bechter, K., Haroon, E., Leonard, B. E., Miller, A., Pariante, C., & Zunszain, P. (2019). The future of psychoneuroimmunology: promises and challenges. Advances in psychiatry, 235-266.
Homan, L. (2020). Psychoneuroimmunology in Children: The Interaction between Psychosocial Stress, the Immune System and the association with Psychopathology (Master's thesis, University of Twente).
Kalinkovich, A., Pouyrovsky, M., Nasyrova, R., & Livshits, G. (2020). Resolution of chronic inflammation as a new adjunctive approach in schizophrenia treatment. Brain, Behavior, and Immunity.
Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G., & Dinan, T. G. (2021). The role of the gut microbiome in the development of schizophrenia. Schizophrenia Research, 234, 4-23. https://doi.org/10.1016/j.schres.2020.02.010
Kelsven, S., de la Fuente-Sandoval, C., Achim, C. L., Reyes-Madrigal, F., Mirzakhanian, H., Domingues, I., & Cadenhead, K. (2020). Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness. Schizophrenia research, 226, 13-23. https://doi.org/10.1016/j.schres.2020.01.003
Kertiasih, N. W., Nopriantha, M., Wahyuni, A. A. S., Diniari, N. K. S., & Kuswardhani, R. A. T. (2023). Association between hemoglobin levels and depression status in geriatric patients at Prof. DR. I. G. N. G. Ngoerah General Hospital. International Journal of Health & Medical Sciences, 6(2), 77-84. https://doi.org/10.21744/ijhms.v6n2.2105
Kohut, M. (2019). Exercise and psychoneuroimmunology. Current Opinion in Behavioral Sciences, 28, 152-162. https://doi.org/10.1016/j.cobeha.2019.06.002
Ma, J., Yan, L., Guo, T., Yang, S., Ni, D., Liu, Y., & Wang, J. (2020). A pilot study of biomarkers of oxidative stress in serum and schizophrenia. Psychiatry Research, 284, 112757. https://doi.org/10.1016/j.psychres.2020.112757
Madison, A., & Kiecolt-Glaser, J. K. (2019). Stress, depression, diet, and the gut microbiota: human–bacteria interactions at the core of psychoneuroimmunology and nutrition. Current opinion in behavioral sciences, 28, 105-110. https://doi.org/10.1016/j.cobeha.2019.01.011
Miller, B. J., & Goldsmith, D. R. (2019). Inflammatory biomarkers in schizophrenia: Implications for heterogeneity and neurobiology. Biomarkers in Neuropsychiatry, 1, 100006. https://doi.org/10.1016/j.bionps.2019.100006
Misiak, B., ?oniewski, I., Marlicz, W., Frydecka, D., Szulc, A., Rudzki, L., & Samochowiec, J. (2020). The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota?. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 102, 109951. https://doi.org/10.1016/j.pnpbp.2020.109951
Müller, N. (2018). Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophrenia bulletin, 44(5), 973-982.
Najjar, S., Steiner, J., Najjar, A., & Bechter, K. (2018). A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis. Journal of Neuroinflammation, 15(1), 1-8.
Slavich, G. M. (2020). Psychoneuroimmunology of stress and mental health.
Soria, V., Uribe, J., Salvat-Pujol, N., Palao, D., Menchón, J. M., & Labad, J. (2018). Psychoneuroimmunology of mental disorders. Revista de Psiquiatría y Salud Mental (English Edition), 11(2), 115-124. https://doi.org/10.1016/j.rpsmen.2017.07.002
Vempati, R. P., & Reddy, H. M. (2019). Psychoneuroimmunology and Genetics. In Immunogenetics. IntechOpen.
Yuan, X., Kang, Y., Zhuo, C., Huang, X. F., & Song, X. (2019). The gut microbiota promotes the pathogenesis of schizophrenia via multiple pathways. Biochemical and biophysical research communications, 512(2), 373-380. https://doi.org/10.1016/j.bbrc.2019.02.152
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health & medical sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health & Medical Sciences (IJHMS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHMS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHMS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
